Irma (imatinib Resistance Mutation Analysis) In Cml

Sample Type	Blood
Pre-test Information	Submit latest BCR-ABL Quantitative report along with the sample.
Report Delivery	18 DAYS
₹ Price	₹ 10900

This test is useful for detecting over 90 known and novel mutations in ABL kinase domain of Ph chromosome including T3151 and P-loop mutations responsible for resistance to Imatinib in CML patients. Imatinib is a Tyrosine kinase inhibitor (TKI) which helps in overcoming mutations to aid in the treatment of CML.